Literature DB >> 23370153

Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?

Anna García-Altés1.   

Abstract

INTRODUCTION: During the twentieth century, vaccination has been one of the measures of greatest public health impact. Vaccine administration has helped reduce the burden of disease and mortality from infectious diseases. At present, there is increasing concern about infectious diseases and the ability of health systems to control them, highlighting the need for evaluation of vaccination programs. The aim of this study was to conduct a systematic review of economic evaluation studies carried out regarding Spain on vaccines.
METHODS: Systematic review. Search of articles in major bibliographic databases available online from January 1983 to June 2011. References identified were limited to full economic evaluations carried out regarding Spain that evaluated vaccination programs. For each of the selected papers, a set of predefined variables were extracted.
RESULTS: A total of 46 studies met inclusion criteria. The topics studied were pneumococcal vaccination, influenza vaccination, Hepatitis B vaccination and varicella vaccination. Cost-minimization analysis, perspective of society, long time horizon, use of modeling techniques, and the inclusion of direct and indirect costs were the most common methodological characteristics. The results of the studies reviewed showed, in most cases, net savings or cost-effectiveness ratios below €30,000/QALY.
CONCLUSIONS: Although there has been an improvement in the methodological quality of studies, they still show shortcomings that should be addressed. From a public health perspective, it would be relevant to evaluate vaccines targeted to major health problems in Spain, including all relevant costs and benefits. In order to obtain a more efficient use of health resources, economic evaluation methods should be applied more rigorously and results should be used consistently in decision-making processes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370153     DOI: 10.1016/j.vaccine.2013.01.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  A systematic review of health economic evaluations of vaccines in Brazil.

Authors:  Ana Marli Christovam Sartori; Luciana Martins Rozman; Tassia Cristina Decimoni; Roseli Leandro; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

2.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

Review 3.  Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance.

Authors:  Chiara Scelfo; Francesco Menzella; Matteo Fontana; Giulia Ghidoni; Carla Galeone; Nicola Cosimo Facciolongo
Journal:  Vaccines (Basel)       Date:  2021-04-22

4.  The cost of vaccination throughout life: A western European overview.

Authors:  Olivier Ethgen; Murielle Cornier; Emilie Chriv; Florence Baron-Papillon
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

Review 5.  Economic evaluations of vaccines in Canada: a scoping review.

Authors:  Ellen R S Rafferty; Heather L Gagnon; Marwa Farag; Cheryl L Waldner
Journal:  Cost Eff Resour Alloc       Date:  2017-05-05

6.  Vaccination: the cornerstone of an efficient healthcare system.

Authors:  Vanessa Rémy; York Zöllner; Ulrike Heckmann
Journal:  J Mark Access Health Policy       Date:  2015-08-12

7.  How much money is spent on vaccines across Western European countries?

Authors:  Olivier Ethgen; Florence Baron-Papillon; Murielle Cornier
Journal:  Hum Vaccin Immunother       Date:  2016-05-25       Impact factor: 3.452

8.  A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia.

Authors:  Francesc López; Martí Català; Clara Prats; Oriol Estrada; Irene Oliva; Núria Prat; Mar Isnard; Roser Vallès; Marc Vilar; Bonaventura Clotet; Josep Maria Argimon; Anna Aran; Jordi Ara
Journal:  Vaccines (Basel)       Date:  2021-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.